Concepedia
Statistics
Publications
8
Citations
312
H-Index
Active since
2009
Affiliations
Pfizer (United States)(Current)
Icahn School of Medicine at Mount Sinai
University Hospital Münster
Michael A. Zielinski is an author at Pfizer (United States) specializing in medicine, pharmacotherapy, and pharmacology.
Top concepts
MedicinePharmacologyPharmacotherapyAsthmaHealthAllergyAnalgesicsPhysiologyDermatologyPain Medicine
Publications per year
2009–2024
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial
Robert Bissonnette, Ana B. Pavel, Aisleen Diaz et al. · Journal of Allergy and Clinical Immunology · 2019 · 123 citations · Full text
Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation
Scott M. Rawls, Michael A. Zielinski, Hiren Patel et al. · Drug and Alcohol Dependence · 2009 · 68 citations · Full text
Pain Medicine, Molecular Pain, Analgesic Tolerance +16
Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups
Valerie Callender, Andrew Alexis, Linda Stein Gold et al. · American Journal of Clinical Dermatology · 2019 · 40 citations · Full text
Patient and caregiver preferences on treatment attributes for atopic dermatitis
Claire Ervin, Rebecca J. Crawford, Emily Evans et al. · Journal of Dermatological Treatment · 2021 · 21 citations · Full text
Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole
Sonja Ständer, Gil Yosipovitch, Andrew G. Bushmakin et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 17 citations
1–5 of 8